+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The molecular mechanism of resistance to methotrexate in mouse methotrexate-resistant cells by cancer drug resistance and metabolism SuperArray



The molecular mechanism of resistance to methotrexate in mouse methotrexate-resistant cells by cancer drug resistance and metabolism SuperArray



Basic and Clinical Pharmacology and Toxicology 99(2): 141-145



Drug resistance is often a limiting factor in successful chemotherapy. Understanding of the molecular mechanism of resistance to methotrexate is important for optimal use as well as for the development of new drugs. Using standard cytogenetic techniques, double minutes (DMs) were detected in mouse methotrexate-resistant cell lines inducted in vitro in this study. Moreover, functional SuperArray, determining the regulation of gene expression corresponding to 96 genes involved in the metabolism of and the development of resistance to cancer drugs was used to study in detail the molecular mechanism of resistance to methotrexate. Significant higher expressions of many genes especially dhfr, mrp5, atm and p53 were detected in methotrexate-resistant cells than in normal mouse cells by SuperArray analysis and corresponding excessive expressions of DHFR, MRP5, ATM, and P53 proteins in methotrexate-resistant cells were also confirmed by Western blot analysis. The results in this study indicated that DHFR, MRP5, ATM, and P53 could play important roles in resistance to methotrexate and some of them would be new potential drug targets.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012666698

Download citation: RISBibTeXText

PMID: 16918715

DOI: 10.1111/j.1742-7843.2006.pto_470.x


Related references

A comparison of the inhibition of growth of methotrexate-resistant and -sensitive leukemia cells in culture by triazines. Evidence for a new mechanism of cell resistance to methotrexate. Journal of Medicinal Chemistry 25(2): 157-161, 1982

Methotrexate Resistance in Datura innoxia (Uptake and Metabolism of Methotrexate in Wild-Type and Resistant Cell Lines). Plant Physiology 101(2): 477-483, 1993

Methotrexate and mitoxantrone cross-resistance in selected drug-resistant MCF7 breast cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 40: 669-670, 1999

Induction of resistance to 7-hydroxymethotrexate can also induce resistance by a different mechanism to the parent drug methotrexate in human leukemic cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 114-115, 2003

Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. International Journal of Oncology 45(1): 448-458, 2015

Evidence for multiple mechanisms of methotrexate resistance in cells displaying atypical multidrug resistance following selection solely with high concentration methotrexate. Proceedings of the American Association for Cancer Research Annual Meeting 31: 372, 1990

Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline. Israel Journal of Medical Sciences 24(9-10): 477-482, 1988

Establishment of methotrexate-resistant human gestational choriocarcinoma cells in culture and analysis of mechanism of resistance. Nihon Sanka Fujinka Gakkai Zasshi 36(11): 2129-2137, 1984

Acquired versus intrinsic resistance to methotrexate: diversity of the drug-resistant phenotype in mammalian cells. Seminars in Cancer Biology 2(4): 245-255, 1991

Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions. Cancer Research 64(16): 5804-5811, 2004

Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines. Journal of Orthopaedic Surgery and Research 10: 136, 2016

Diallyl trisulfide reverses drug resistance and lowers the ratio of CD133+ cells in conjunction with methotrexate in a human osteosarcoma drug-resistant cell subline. Molecular Medicine Reports 2(2): 245-252, 2009

Methotrexate cross-resistance in human ovarian cancer cells resistant to cisplatin. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 401, 1993

Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated by counterflow elutriation. Bone Marrow Transplantation 24(8): 815-821, Oct 2, 1999

Mutation in a putative reduced folate carrier contributes to methotrexate resistance in the methotrexate resistant cell line DC-3F/A55. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 376, 1995